Cargando…

The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells

BACKGROUND: Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic u...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Jeong Yong, Kim, Seung Won, Park, Ki Cheong, Yun, Mijin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562121/
https://www.ncbi.nlm.nih.gov/pubmed/26345371
http://dx.doi.org/10.1186/s12885-015-1640-z
_version_ 1782389117533814784
author Jeon, Jeong Yong
Kim, Seung Won
Park, Ki Cheong
Yun, Mijin
author_facet Jeon, Jeong Yong
Kim, Seung Won
Park, Ki Cheong
Yun, Mijin
author_sort Jeon, Jeong Yong
collection PubMed
description BACKGROUND: Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic units and energy sources, which are the most important sources for making the ATP that maintains homeostasis in cancer cell growth and survival. Therefore, the glucose analog 2-deoxyglucose (2DG) has been used as an anticancer reagent due to its inhibition of glycolysis. METHODS: Prostate cancer cells (PC3) were treated with 2DG for 6 h or 48 h to analyze the changing of cell cycle and autophagic flux. Rapamycin and LC3B overexpressing vectors were administered to PC3 cells for autophagy induction and chloroquine and shBeclin1 plasmid were used to inhibit autophagy in PC3 cells to analyze PC3 cells growth and survival. The samples for western blotting were prepared in each culture condition to confirm the expression level of autophagy related and regulating proteins. RESULTS: We demonstrated that 2DG inhibits PC3 cells growth and had discriminating effects on autophagy regulation based on the different time period of 2DG treatment to control cell survival. Short-term treatment of 2DG induced autophagic flux, which increased microtubule associated protein 1 light chain 3B (LC3B) conversion rates and reduced p62 levels. However, 2DG induced autophagic flux is remarkably reduced over an extended time period of 2DG treatment for 48 h despite autophagy inducing internal signaling being maintained. The relationship between cell growth and autophagy was proved. Increased autophagic flux by rapamycin or LC3B overexpression powerfully reduced cell growth, while autophagy inhibition with shBeclin1 plasmid or chloroquine had no significant effect on regulating cell growth. CONCLUSION: Given these results, maintaining increased autophagic flux was more effective at inhibiting cancer cell progression than inhibition of autophagic flux, which is necessary for the survival of PC3 cells. Autophagic flux should be tightly regulated to maintain metabolic homeostasis for cancer cell growth and survival in PC3 cells and is a suitable target for cancer therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1640-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4562121
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45621212015-09-09 The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells Jeon, Jeong Yong Kim, Seung Won Park, Ki Cheong Yun, Mijin BMC Cancer Research Article BACKGROUND: Recent reports using metabolism regulating drugs showed that nutrient deprivation was an efficient tool to suppress cancer progression. In addition, autophagy control is emerging to prevent cancer cell survival. Autophagy breaks down the unnecessary cytoplasmic components into anabolic units and energy sources, which are the most important sources for making the ATP that maintains homeostasis in cancer cell growth and survival. Therefore, the glucose analog 2-deoxyglucose (2DG) has been used as an anticancer reagent due to its inhibition of glycolysis. METHODS: Prostate cancer cells (PC3) were treated with 2DG for 6 h or 48 h to analyze the changing of cell cycle and autophagic flux. Rapamycin and LC3B overexpressing vectors were administered to PC3 cells for autophagy induction and chloroquine and shBeclin1 plasmid were used to inhibit autophagy in PC3 cells to analyze PC3 cells growth and survival. The samples for western blotting were prepared in each culture condition to confirm the expression level of autophagy related and regulating proteins. RESULTS: We demonstrated that 2DG inhibits PC3 cells growth and had discriminating effects on autophagy regulation based on the different time period of 2DG treatment to control cell survival. Short-term treatment of 2DG induced autophagic flux, which increased microtubule associated protein 1 light chain 3B (LC3B) conversion rates and reduced p62 levels. However, 2DG induced autophagic flux is remarkably reduced over an extended time period of 2DG treatment for 48 h despite autophagy inducing internal signaling being maintained. The relationship between cell growth and autophagy was proved. Increased autophagic flux by rapamycin or LC3B overexpression powerfully reduced cell growth, while autophagy inhibition with shBeclin1 plasmid or chloroquine had no significant effect on regulating cell growth. CONCLUSION: Given these results, maintaining increased autophagic flux was more effective at inhibiting cancer cell progression than inhibition of autophagic flux, which is necessary for the survival of PC3 cells. Autophagic flux should be tightly regulated to maintain metabolic homeostasis for cancer cell growth and survival in PC3 cells and is a suitable target for cancer therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1640-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-07 /pmc/articles/PMC4562121/ /pubmed/26345371 http://dx.doi.org/10.1186/s12885-015-1640-z Text en © Jeon et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jeon, Jeong Yong
Kim, Seung Won
Park, Ki Cheong
Yun, Mijin
The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
title The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
title_full The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
title_fullStr The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
title_full_unstemmed The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
title_short The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
title_sort bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562121/
https://www.ncbi.nlm.nih.gov/pubmed/26345371
http://dx.doi.org/10.1186/s12885-015-1640-z
work_keys_str_mv AT jeonjeongyong thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT kimseungwon thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT parkkicheong thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT yunmijin thebifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT jeonjeongyong bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT kimseungwon bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT parkkicheong bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells
AT yunmijin bifunctionalautophagicfluxby2deoxyglucosetocontrolsurvivalorgrowthofprostatecancercells